{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:54:43Z","timestamp":1791453283812,"version":"4.3.3"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003185","name":"Fraunhofer-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.tox.2024.153743","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:51:54Z","timestamp":1707439914000},"page":"153743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A novel three-dimensional Nrf2 reporter epidermis model for skin sensitization assessment"],"prefix":"10.1016","volume":"503","author":[{"given":"K.","family":"Brandmair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Dising","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Finkelmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schepky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kuehnl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ebmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Burger-Kentischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2024.153743_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.104936","article-title":"Next generation risk assessment for skin sensitisation: a case study with propyl paraben","volume":"123","author":"Assaf Vandecasteele","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.tox.2024.153743_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/cosmetics9020038","article-title":"Skin sensitization testing: the ascendancy of non-animal methods","volume":"9","author":"Basketter","year":"2022","journal-title":"Cosmetics"},{"key":"10.1016\/j.tox.2024.153743_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/DER.0000000000000003","article-title":"Categorization of chemicals according to their relative human skin sensitizing potency","volume":"25","author":"Basketter","year":"2014","journal-title":"Dermatitis"},{"key":"10.1016\/j.tox.2024.153743_bib4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.14573\/altex.1701311","article-title":"Adaptation of the KeratinoSens\u2122 skin sensitization test to animal-product-free cell culture","volume":"34","author":"Belot","year":"2017","journal-title":"ALTEX"},{"key":"10.1016\/j.tox.2024.153743_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jim.2010.03.020","article-title":"A new cell-based innate immune receptor assay for the examination of receptor activity, ligand specificity, signalling pathways and the detection of pyrogens","volume":"358","author":"Burger-Kentischer","year":"2010","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.tox.2024.153743_bib6","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1038\/onc.2017.153","article-title":"A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer","volume":"36","author":"Choi","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.tox.2024.153743_bib7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.tiv.2015.02.012","article-title":"Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay","volume":"29","author":"Cottrez","year":"2015","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.tox.2024.153743_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tiv.2016.01.007","article-title":"SENS-IS, a 3D reconstituted epidermis based model for quantifying chemical sensitization potency: reproducibility and predictivity results from an inter-laboratory study","volume":"32","author":"Cottrez","year":"2016","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.tox.2024.153743_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.104644","article-title":"In vitro measurement of skin sensitization hazard of mixtures and finished products: results obtained with the SENS-IS assays","volume":"62","author":"Cottrez","year":"2020","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.tox.2024.153743_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.14573\/altex.1705101","article-title":"Fetal Bovine Serum (FBS): past - present - future","volume":"35","author":"van der Valk","year":"2018","journal-title":"ALTEX"},{"key":"10.1016\/j.tox.2024.153743_bib11","unstructured":"EC, 2009. Regulation (EC) No 1223\/2009 of the European Parliament and of the Council of 30 November 2009 on Cosmetic Products. OJ L342, 64. https:\/\/doi.org\/10.3000\/17252555.L_2009.342.eng."},{"key":"10.1016\/j.tox.2024.153743_bib12","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00204-014-1218-6","article-title":"Comparison of xenobiotic metabolizing enzyme activities in ex vivo human skin and reconstructed human skin models from SkinEthic","volume":"88","author":"Eilstein","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2024.153743_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.taap.2010.03.009","article-title":"Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro","volume":"245","author":"Emter","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2024.153743_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tiv.2018.01.021","article-title":"Predicting skin sensitizers with confidence - Using conformal prediction to determine applicability domain of GARD","volume":"48","author":"Forreryd","year":"2018","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.tox.2024.153743_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104721","article-title":"Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients","volume":"116","author":"Gilmour","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2024.153743_bib16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1600-0625.2012.01478.x","article-title":"Xenobiotic metabolism capacities of human skin in comparison with a 3D-epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: phase II enzymes","volume":"21","author":"G\u00f6tz","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.tox.2024.153743_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1600-0625.2012.01486.x","article-title":"Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I)","volume":"21","author":"G\u00f6tz","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.tox.2024.153743_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0022-1759(94)90244-5","article-title":"A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phosphatase (SEAP)","volume":"170","author":"Gregory","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.tox.2024.153743_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/toxsci\/kft080","article-title":"Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations","volume":"133","author":"Hewitt","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2024.153743_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105169","article-title":"Expansion of the cosmetics Europe skin sensitisation database with new substances and PPRA data","volume":"131","author":"Hoffmann","year":"2022","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2024.153743_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5661\/bger-25-41","article-title":"Recent developments of biological reporter technology for detecting gene expression","volume":"25","author":"Jiang","year":"2008","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.tox.2024.153743_bib22","first-page":"515","article-title":"Evaluation of the GARD assay in a blind Cosmetics Europe study","volume":"34","author":"Johansson","year":"2017","journal-title":"ALTEX"},{"key":"10.1016\/j.tox.2024.153743_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1034\/j.1600-0536.2002.470601.x","article-title":"The local lymph node assay: past, present and future","volume":"47","author":"Kimber","year":"2002","journal-title":"Contact Dermat."},{"key":"10.1016\/j.tox.2024.153743_bib24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.yrtph.2019.05.016","article-title":"A review of substances found positive in 1 of 3 in vitro tests for skin sensitization","volume":"106","author":"Kolle","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2024.153743_bib25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/978-1-4939-6515-1_25","article-title":"Immune cell-supplemented human skin model for studying fungal infections","volume":"1508","author":"K\u00fchbacher","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tox.2024.153743_bib26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jsbmb.2009.05.011","article-title":"Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models Episkin and full thickness model from Episkin.","volume":"116","author":"Luu-The","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tox.2024.153743_bib27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/jid.1969.42","article-title":"The identification of contact allergens by animal assay. The guinea pig maximization test","volume":"52","author":"Magnusson","year":"1969","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tox.2024.153743_bib28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jat.4076","article-title":"Characterization of dermal sensitization potential for industrial or agricultural chemicals with EpiSensA","volume":"41","author":"Mizumachi","year":"2021","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tox.2024.153743_bib29","article-title":"Reconstructed human epidermis-based testing strategy of skin sensitization potential and potency classification using epidermal sensitization assay and in silico data","author":"Mizumachi","year":"2023","journal-title":"J. Appl. Toxicol. Adv. Online Publ."},{"key":"10.1016\/j.tox.2024.153743_bib30","article-title":"The inter-laboratory validation study of EpiSensA for predicting skin sensitization potential","author":"Mizumachi","year":"2023","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tox.2024.153743_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.tox.2024.153743_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105128","article-title":"Benchmarking performance of SENS-IS assay against weight of evidence skin sensitization potency categories","volume":"130","author":"Na","year":"2022","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2024.153743_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/toxsci\/kfm259","article-title":"Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals","volume":"102","author":"Natsch","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2024.153743_bib34","first-page":"652","article-title":"Predictivity of the kinetic direct peptide reactivity assay (kDPRA) for sensitizer potency assessment and GHS subclassification","volume":"37","author":"Natsch","year":"2020","journal-title":"ALTEX"},{"key":"10.1016\/j.tox.2024.153743_bib35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0006-2952(99)00096-9","article-title":"Reporter gene technology: the future looks bright","volume":"58","author":"Naylor","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2024.153743_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2131\/jts.44.23","article-title":"The dermal sensitization threshold (DST) approach for mixtures evaluated as negative in in vitro test methods; mixture DST","volume":"44","author":"Nishijo","year":"2019","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.tox.2024.153743_bib37","doi-asserted-by":"crossref","unstructured":"OECD, 2014. The Adverse outcome pathway for skin sensitisation initiated by covalent binding to proteins, OECD Series on Testing and Assessment, No. 168, OECD Publishing, Paris. https:\/\/doi.org\/10.1787\/9789264221444-en.","DOI":"10.1787\/9789264221444-en"},{"key":"10.1016\/j.tox.2024.153743_bib38","doi-asserted-by":"crossref","unstructured":"OECD, 2019. Test No. 431: In vitro skin corrosion: reconstructed human epidermis (RHE) test method, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris., https:\/\/doi.org\/10.1787\/9789264264618-en.","DOI":"10.1787\/9789264264618-en"},{"key":"10.1016\/j.tox.2024.153743_bib39","doi-asserted-by":"crossref","unstructured":"OECD, 2021. Test No. 439: In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris. https:\/\/doi.org\/10.1787\/9789264242845-en.","DOI":"10.1787\/9789264242845-en"},{"key":"10.1016\/j.tox.2024.153743_bib40","doi-asserted-by":"crossref","unstructured":"OECD, 2022a. Test No. 442C: In Chemico Skin Sensitisation: Assays addressing the Adverse Outcome Pathway key event on covalent binding to proteins, OECD Guidelines for the Testing of Chemicals, Section 4, \u00c9ditions OCDE, Paris. https:\/\/doi.org\/10.1787\/9789264229709-en.","DOI":"10.1787\/9789264229709-en"},{"key":"10.1016\/j.tox.2024.153743_bib41","doi-asserted-by":"crossref","unstructured":"OECD, 2022b. Test No. 442D: In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris. https:\/\/doi.org\/10.1787\/9789264229822-en.","DOI":"10.1787\/9789264229822-en"},{"key":"10.1016\/j.tox.2024.153743_bib42","doi-asserted-by":"crossref","unstructured":"OECD, 2022c. Test No. 442E: In Vitro Skin Sensitisation: In Vitro Skin Sensitisation assays addressing the Key Event on activation of dendritic cells on the Adverse Outcome Pathway for Skin Sensitisation, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris. https:\/\/doi.org\/10.1787\/9789264264359-en.","DOI":"10.1787\/9789264264359-en"},{"key":"10.1016\/j.tox.2024.153743_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.yrtph.2018.07.020","article-title":"Assessment of the skin sensitisation hazard of functional polysiloxanes and silanes in the SENS-IS assay","volume":"98","author":"Petry","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2024.153743_bib44","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.tiv.2014.08.002","article-title":"LuSens: a keratinocyte based ARE reporter gene assay for use in integrated testing strategies for skin sensitization hazard identification","volume":"28","author":"Ramirez","year":"2014","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.tox.2024.153743_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-0716-0648-3_5","article-title":"Organotypic 3D skin models: human epidermal equivalent cultures from primary keratinocytes and immortalized keratinocyte cell lines","volume":"2154","author":"Rikken","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tox.2024.153743_bib46","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.tiv.2013.08.007","article-title":"Development of a new in vitro skin sensitization assay (Epidermal sensitization assay; EpiSensA) using reconstructed human epidermis","volume":"27","author":"Saito","year":"2013","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.tox.2024.153743_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tiv.2016.12.005","article-title":"An in vitro skin sensitization assay termed EpiSensA for broad sets of chemicals including lipophilic chemicals and pre\/pro-haptens","volume":"40","author":"Saito","year":"2017","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.tox.2024.153743_bib48","unstructured":"SCCS), 2023. Notes of Guidance. https:\/\/health.ec.europa.eu\/latest-updates\/sccs-notes-guidance-testing-cosmetic-ingredients-and-their-safety-evaluation-12th-revision-2023-05-16_en."},{"key":"10.1016\/j.tox.2024.153743_bib49","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.yrtph.2014.12.008","article-title":"Assessing skin sensitization hazard in mice and men using non-animal test methods","volume":"71","author":"Urbisch","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2024.153743_bib50","first-page":"97","article-title":"Chemically defined serum-free and xeno-free media for multiple cell lineages","volume":"2","author":"Usta","year":"2014","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.tox.2024.153743_bib51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.14573\/altex.1709011","article-title":"State-of-the-art and new options to assess T cell activation by skin sensitizers: cosmetics Europe workshop","volume":"35","author":"van Vliet","year":"2018","journal-title":"ALTEX"},{"key":"10.1016\/j.tox.2024.153743_bib52","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2144\/97236pf01","article-title":"Quantification of gene expression with a secreted alkaline phosphatase reporter system","volume":"23","author":"Yang","year":"1997","journal-title":"BioTechniques"},{"key":"10.1016\/j.tox.2024.153743_bib53","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1021\/acs.jcim.6b00070","article-title":"Computational discovery and experimental confirmation of TLR9 receptor antagonist leads","volume":"56","author":"Zatsepin","year":"2016","journal-title":"J. Chem. Inf. Model."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X24000246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X24000246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:56:25Z","timestamp":1759535785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X24000246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":53,"alternative-id":["S0300483X24000246"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2024.153743","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel three-dimensional Nrf2 reporter epidermis model for skin sensitization assessment","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2024.153743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"153743"}}